St Petersburg, FLNCT06740799Now EnrollingIRB Ready

Hepatic Impairment Clinical Trial in St Petersburg, FL

Access cutting-edge hepatic impairment treatment through this clinical trial at a research site in St Petersburg. Study-provided care at no cost to qualified participants.

Sponsored by Daiichi Sankyo

Quick Self-Assessment

See if you qualify for this St Petersburg location

Preparing your pre-screening questions…

Expert Care in St Petersburg

Access hepatic impairment specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hepatic impairment treatment provided free

Apply for This St Petersburg Location

Check if you qualify for this hepatic impairment clinical trial in St Petersburg, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Petersburg

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Petersburg site if eligible
  4. 4Begin participation

About This Hepatic Impairment Study in St Petersburg

This study will evaluate and compare the PK in subjects with severe HI to that of matched healthy control subjects with normal hepatic function.

Sponsor: Daiichi Sankyo

Who Can Participate

Inclusion Criteria

Voluntarily consents to participate in this study and provides written informed consent before the start of any study-specific procedures.
Male and female subjects 18 to 75 years of age (inclusive), with a body mass index (BMI) of 18 kg/m2 to 37 kg/m2 (inclusive) with a minimum body weight of 40 kg at Screening.
In females, documented surgical sterilization (ie, documented hysterectomy, bilateral tubal ligation, or bilateral salpingo-oophorectomy, Essure® with hysterosalpingogram \[documentation to confirm tubal occlusion 12 weeks after procedure\]), postmenopausal status for at least 1 year (follicle stimulating hormone \[FSH\] \> 40 mIU/mL serum and estradiol \<40 pg/mL \[\<147 pmol/L\] at Screening), or agreement to have a sterile male partner, or agreement to use 1 of the means of contraception from Screening until 7 months after the dose of quizartinib 4. In females, agreement to not retrieve eggs/ova via assisted reproductive technology (ART) either for their own use or donation while on the study or for 7 months after the last dose of study drug, whichever is later. 5\. In males, documented surgical sterilization, sexual abstinence, or agreement to use 1 of the means of contraception from Screening until 4 months after the dose of quizartinib 6. In males, agreement to avoid sperm donation for 4 months after the dose of quizartinib Key

Exclusion Criteria

Any serious and/or unstable pre-existing medical, psychiatric disorder, or other conditions (including lab abnormality except hepatic impairment) that could interfere with safety, obtaining informed consent, compliance to the study procedures, or the validity of the study results.
In the opinion of the investigator, history of a clinically significant illness within 4 weeks prior to administration of quizartinib.
Subjects with primary biliary cirrhosis or primary sclerosing cholangitis.
Subjects with history of Gilbert's syndrome.
Presence or history of clinically severe adverse reaction to any drug or known hypersensitivity to any of the ingredients (including inactive ingredients) of quizartinib.
History of stomach or intestinal surgery or resection that would potentially alter absorption and/or excretion of orally administered drugs (with the exception of appendectomy, hernia repair, and/or cholecystectomy).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Petersburg?

Yes, this clinical trial (NCT06740799) has an active research site in St Petersburg, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hepatic Impairment Treatment Options in St Petersburg, FL

If you're searching for hepatic impairment treatment options in St Petersburg, FL, this clinical trial (NCT06740799) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Petersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatic impairment specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hepatic impairment clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in St Petersburg, FL

See all interstitial cystitis clinical trials recruiting in St Petersburg — not just this study.

Browse Interstitial Cystitis Trials in St Petersburg →

Browse More Trials by Condition

Interstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in St Petersburg?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Petersburg, FL